Markus Puhlmann - Net Worth and Insider Trading
Markus Puhlmann Net Worth
The estimated net worth of Markus Puhlmann is at least $2 Million dollars as of 2024-05-24. Markus Puhlmann is the Chief Medical Officer of Perspective Therapeutics Inc and owns about 1,375,425 shares of Perspective Therapeutics Inc (CATX) stock worth over $2 Million. Details can be seen in Markus Puhlmann's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Markus Puhlmann has not made any transactions after 2024-01-24 and currently still holds the listed stock(s).
Transaction Summary of Markus Puhlmann
Markus Puhlmann Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Markus Puhlmann owns 1 companies in total, including Perspective Therapeutics Inc (CATX) .
Click here to see the complete history of Markus Puhlmann’s form 4 insider trades.
Insider Ownership Summary of Markus Puhlmann
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CATX | Perspective Therapeutics Inc | 2024-01-24 | Chief Medical Officer |
Markus Puhlmann Latest Holdings Summary
Markus Puhlmann currently owns a total of 1 stock. Markus Puhlmann owns 1,375,425 shares of Perspective Therapeutics Inc (CATX) as of January 24, 2024, with a value of $2 Million.
Latest Holdings of Markus Puhlmann
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CATX | Perspective Therapeutics Inc | 2024-01-24 | 1,375,425 | 1.60 | 2,193,803 |
Holding Weightings of Markus Puhlmann
Markus Puhlmann Form 4 Trading Tracker
According to the SEC Form 4 filings, Markus Puhlmann has made a total of 2 transactions in Perspective Therapeutics Inc (CATX) over the past 5 years, including 2 buys and 0 sells. The most-recent trade in Perspective Therapeutics Inc is the acquisition of 280,000 shares on January 24, 2024, which cost Markus Puhlmann around $140,000.
Insider Trading History of Markus Puhlmann
- 1
Markus Puhlmann Trading Performance
GuruFocus tracks the stock performance after each of Markus Puhlmann's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Markus Puhlmann is 238.78%. GuruFocus also compares Markus Puhlmann's trading performance to market benchmark return within the same time period. The performance of stocks bought by Markus Puhlmann within 3 months outperforms 2 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Markus Puhlmann's insider trading performs compared to the benchmark.
Performance of Markus Puhlmann
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 68.9 |  | | | | |
| Relative Return to S&P 500(%) | 65.89 | | | | | |
Markus Puhlmann Ownership Network
Markus Puhlmann Owned Company Details
What does Perspective Therapeutics Inc do?
Who are the key executives at Perspective Therapeutics Inc?
Markus Puhlmann is the Chief Medical Officer of Perspective Therapeutics Inc. Other key executives at Perspective Therapeutics Inc include Chief Financial Officer Jonathan Robert Hunt , Vice President Lori A Woods , and director & CEO Johan M. Spoor .
Perspective Therapeutics Inc (CATX) Insider Trades Summary
Over the past 18 months, Markus Puhlmann made 2 insider transaction in Perspective Therapeutics Inc (CATX) with a net purchase of 875,425. Other recent insider transactions involving Perspective Therapeutics Inc (CATX) include a net purchase of 342,424 shares made by Williamson Robert F Iii , a net purchase of 210,404 shares made by Jonathan Robert Hunt , and a net purchase of 60,431,039 shares made by .
In summary, during the past 3 months, insiders sold 0 shares of Perspective Therapeutics Inc (CATX) in total and bought 60,431,039 shares, with a net purchase of 60,431,039 shares. During the past 18 months, 0 shares of Perspective Therapeutics Inc (CATX) were sold and 62,044,492 shares were bought by its insiders, resulting in a net purchase of 62,044,492 shares.
Perspective Therapeutics Inc (CATX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Perspective Therapeutics Inc Insider Transactions
Markus Puhlmann Mailing Address
Above is the net worth, insider trading, and ownership report for Markus Puhlmann. You might contact Markus Puhlmann via mailing address: 350 Hills Street, Suite 106, Richland Wa 99354.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
